<DOC>
	<DOC>NCT00000330</DOC>
	<brief_summary>The purpose of this study is to assess the abuse liability and reinforcing effects of intravenous buprenorphine and buprenorphine/naloxone combinations in heroin-dependent volunteers</brief_summary>
	<brief_title>Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5</brief_title>
	<detailed_description>not available at this time</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Analgesics, Opioid</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Buprenorphine, Naloxone Drug Combination</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<criteria>Individuals must be at least 18 yrs of age, currently opioid dependent and must not be seeking treatment. Comorbid substance abuse or dependence disorders may also be present. Individuals must be healthy despite drug dependency and have a history of IV opioid use. Individuals with evidence of an active Diagnostic and Statistical Manual of Mental Disorders (DSMIV) Axis I psychiatric disorder (e.g. psychosis, manicdepressive illness, organic psychiatric disorders), significant medical illness (e.g. liver or cardiovascular disease) or pregnant female subjects are excluded from study participation.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Heroin Dependence</keyword>
</DOC>